Clinical Trial Update: The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer

View source ↗

Summary

Clinical trial update examining the role of PET imaging during erlotinib treatment for non-small cell lung cancer, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Asan Medical Center | Conditions: Erlotinib, Lung Cancer | Status: UNKNOWN